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The vertebrate gut symbiont Lactobacillus reuteri exhibits strain-specific adhesion and
health-promoting properties. Here, we investigated the role of the mucus adhesins,
CmbA and MUB, upon interaction of L. reuteri ATCC PTA 6475 and ATCC 53608
strains with human monocyte-derived dendritic cells (moDCs). We showed that mucus
adhesins increased the capacity of L. reuteri strains to interact with moDCs and
promoted phagocytosis. Our data also indicated that mucus adhesins mediate anti-
and pro-inflammatory effects by the induction of interleukin-10 (IL-10), tumor necrosis
factor alpha (TNF-α), IL-1β, IL-6, and IL-12 cytokines. L. reuteri ATCC PTA 6475
and ATCC 53608 were exclusively able to induce moDC-mediated Th1 and Th17
immune responses. We further showed that purified MUB activates moDCs and induces
Th1 polarized immune responses associated with increased IFNγ production. MUB
appeared to mediate these effects via binding to C-type lectin receptors (CLRs), as
shown using cell reporter assays. Blocking moDCs with antibodies against DC-specific
intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) or Dectin-2 did not
affect the uptake of the MUB-expressing strain, but reduced the production of TNF-
α and IL-6 by moDCs significantly, in line with the Th1 polarizing capacity of moDCs.
The direct interaction between MUB and CLRs was further confirmed by atomic force
spectroscopy. Taken together these data suggest that mucus adhesins expressed at the
cell surface of L. reuteri strains may exert immunoregulatory effects in the gut through
modulating the Th1-promoting capacity of DCs upon interaction with C-type lectins.
Keywords: L. reuteri, probiotic, mucus adhesins, dendritic cells, C-type lectins, DC-SIGN, Dectin-2,
T-lymphocytes
INTRODUCTION
The gastrointestinal (GI) tract harbors a vast and diverse community of commensal bacteria
(microbiota) which has co-evolved with the host (Walter and Ley, 2011). The gut microbiota
provides a range of benefits to the host including the digestion of complex carbohydrates,
production of metabolites, detoxification, protection against pathogens, and the development
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and regulation of the immune system (Sun and Chang, 2014). The
intestinal immune system negotiates a delicate balance between
immunogenicity against invading pathogens and tolerance to
the commensal microbiota (Mann and Li, 2014). Lactobacillus
reuteri is a common inhabitant of the GI tract of vertebrates
and displays remarkable host adaptation. L. reuteri has diversified
into separate phylogenetic clades reflecting host origin (Oh
et al., 2010) with genomic differences reflecting the niche
characteristics of the host GI tract (Frese et al., 2011). We
previously reported that the adhesion of L. reuteri strains to
mucus is strain-specific, correlating with the presence of host-
clade mucus-binding proteins (MacKenzie et al., 2010; Etzold
et al., 2014b). L. reuteri adhesins include mucus-binding proteins,
MUB (Roos and Jonsson, 2002; MacKenzie et al., 2009, 2010;
Etzold et al., 2014a) and CmbA (Jensen et al., 2014; Etzold
et al., 2014b), and serine-rich-repeat (SRR) proteins (Frese
et al., 2013; Wegmann et al., 2015). L. reuteri exhibits strain-
specific beneficial properties relevant to human health, including
exclusion and inhibition of the growth of intestinal pathogens,
maintenance of the gut barrier integrity, and modulation of
the host immune system at both local and systemic levels (as
reviewed in Walter et al., 2011).
Dendritic cells (DCs) are pivotal in the initiation of
adaptive immune responses and can directly contact and
internalize intestinal bacteria (Rescigno et al., 2001). Further,
DCs can undergo tissue conditioning by intestinal epithelial
cells that control the DC inflammatory potential (Iliev et al.,
2009). Accordingly, the intestinal milieu represents a unique
environment conditioned by all-trans retinoic-acid (ATRA),
where metabolite production is increased by peroxisome
proliferator-activated receptor gamma (PPARγ) in both CD1a−
CD1d+ human monocyte-derived DCs (moDCs) in vitro
(Szatmari et al., 2006; Gogolak et al., 2007) and in human
intestinal DCs (Gyöngyösi et al., 2013). T-lymphocytes primed
by DCs with monocyte precursors play an important role
in the maintenance of self-tolerance against gut commensal
bacteria (Persson et al., 2013). DCs use pattern recognition
receptors (PRRs), such as Toll-like receptors (TLRs) or C-type
lectin receptors (CLRs) to sense various microbe-associated
molecular patterns (MAMPs). In the gut, DCs are able
to distinguish between different members of the microbiota
(Diebold, 2009; Feng et al., 2012) and drive the activation
and differentiation of naive T-lymphocytes into either effector
(Th1, Th17) or regulatory T cells (Treg) (Geijtenbeek and
Gringhuis, 2009; Rescigno, 2014). In addition, the nature of
T-lymphocyte polarizing signals is largely determined by the type
of microbial products, inflammatory signals, or both encountered
in peripheral tissues during the immature phase (Geijtenbeek
and Gringhuis, 2009; Hooper and Macpherson, 2010; Rescigno,
2014).
L. reuteri has been shown to have immunomodulatory
properties and promote mucosal tolerance in the vertebrate GI
tract. Specific probiotic strains of L. reuteri were recently shown
to suppress intestinal inflammation in a trinitrobenzene sulfonic-
acid (TNBS)-induced mouse colitis model via down-regulation
of gene expression of the mucosal cytokine IL-6 and IL-1β in
the colon (Gao et al., 2015). L. reuteri 100-23 stimulated the
development of an increased number of regulatory T cells in
mice (Livingston et al., 2010). Immunomodulation was also
reported in piglets following oral administration of L. reuteri
I5007, resulting in an increased level of TGF-β and a decrease
in IFNγ gene expression in the mesenteric lymph nodes (Hou
et al., 2015). In humans, L. reuteri ATCC 55730 was shown
to temporarily colonize the stomach and the small intestine of
healthy subjects and thus increase CD4+ helper T-lymphocyte
numbers in the ileum (Valeur et al., 2004). However, the
modulation of cytokine production by L. reuteri appears to be
strain-dependent, as demonstrated in vitro. For example, anti-
inflammatory L. reuteri strains ATCC PTA 6475 and ATCC PTA
5289, but not the immuno-stimulatory L. reuteri strains ATCC
55730 and CF48–3A, suppressed TNF-α production induced by
bacterial lipopolysaccharide (LPS)-activated monocytic cells (Lin
et al., 2008; Jones and Versalovic, 2009). Moreover, a recent study
showed that L. reuteri strains from human-associated clades
differed in their ability to modulate human cytokine production
(TNF-α, monocyte chemoattractant protein-1 (MCP-1), IL-1β,
IL-5, IL-7, IL-12, and IL-13) by myeloid cells (Spinler et al., 2014).
The bacterial molecule(s) responsible for down-regulating TNF-α
in antigen presenting cells have not been identified to date but
appear to be strain-specific (Lin et al., 2008; Jones and Versalovic,
2009).
Recently, it was suggested that cell-surface proteins may
play a role in regulating the immunomodulatory properties of
lactobacilli (Lebeer et al., 2008; Meijerink et al., 2010; Remus
et al., 2013; Call et al., 2015; Jensen et al., 2015). However, the
detailed molecular mechanisms by which L. reuteri may interact
with DCs to modulate immune responses and promote mucosal
homeostasis are not well understood. The aim of this work was to
investigate the role of L. reuteri strain-specific mucus adhesins
on the modulation of pro- and anti-inflammatory cytokine
production by human moDCs and the participation of CLRs in
this process.
MATERIALS AND METHODS
Bacterial Strains and Reagents
L. reuteri ATCC PTA 6475 and L. reuteri ATCC PTA 6475
lar_0958 KO mutant (6475-KO) (Etzold et al., 2014b), and
L. reuteri ATCC 53608 and 1063N isolates (MacKenzie et al.,
2010) were used in this study. The anti-Mub antibody is
described in MacKenzie et al. (2010). SIGN-R1 was purchased
from Sino Biological (Beijing, China), DC-SIGN from Caltag-
Medsystems Ltd (Buckingham, UK), and Dectin-1 and Dectin-2
from R&D Systems (Abingdon, UK). The anti-human Dectin-
2 (HDECT2) IgG was from Invitrogen (Toulouse, France)
and the DC-SIGN/CD209 mAb (clone 120507) from Abcam,
(Cambridge, UK).
Human moDC Cultures
Leukocyte-enriched buffy coats were obtained from healthy
blood donors at the Regional Blood Center of the Hungarian
National Blood Transfusion Service (Debrecen, Hungary) in
accordance with the written approval of the Director of
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the National Blood Transfusion Service of the University of
Debrecen, Faculty of Medicine (Hungary). Peripheral blood
mononuclear cells (PBMCs) were separated by a standard density
gradient centrifugation with Ficoll-Paque Plus (Amersham
Biosciences, Uppsala, Sweden). Monocytes were purified from
PBMCs by positive selection using immunomagnetic cell
separation using anti-CD14 microbeads, according to the
manufacturer’s instruction (Miltenyi Biotec, Bergisch Gladbach,
Germany). After separation on a VarioMACS magnet, 96–99%
of the cells were shown to be CD14+ monocytes, as measured
by flow cytometry. Isolated monocytes were cultured in
12-well tissue culture plates at a density of 5.0 × 105
cells/ml in Gibco’s serum-free AIM-V medium (Invitrogen,
Carlsbad, CA, USA), supplemented with 80 ng/ml granulocyte-
monocyte stimulating factor (GM-CSF) (Gentaur Molecular
Products, Brussels, Belgium) and 100 ng/ml interleukin-4 (IL-4)
(PeproTech EC, London, UK). The cells were differentiated in the
presence or absence of 1 nM ATRA (Sigma–Aldrich, Schnelldorf,
Germany) at 37◦C atmosphere containing 5% CO2.
Phagocytosis Assay
Live bacterial cells were centrifuged at 1000 × g for 5 min and
washed three times in 25 ml phosphate buffered saline (PBS).
Suspensions of bacterial cells were heat inactivated by heating
at 65◦C for 45 min and re-suspended in 0.25 M carbonate-
bicarbonate buffer (pH 9.0). The bacterial cell suspensions
(900 µl) were stained with 100 µl fluorescein-isothiocyanate
(FITC) dissolved at 5 mg/ml in dimethyl-sulfoxide (DMSO) and
were rotated overnight at 4◦C in dark. FITC-labeled bacteria were
washed three times with cold PBS and were co-incubated for 3 h
with moDCs at 37◦C or 4◦C at a moDC:bacteria ratio of 1:20. The
moDCs positive for FITC-labeled bacteria were analyzed by flow
cytometry.
Growth of Bacteria for moDC Activation
L. reuteri strains were grown in DifcoTM de Man, Rogosa and
Sharpe (MRS) broth medium for 18 h stationary at 37◦C (MRS,
BD BioSciences, Franklin Lakes, NJ, USA). Bacterial suspensions
were washed with 25 ml sterile PBS buffer three times and
OD600 nm was measured by spectrophotometry and converted to
cell/ml following OD600 nm × 2.5 × 108 CFU/ml (Regulski et al.,
2012). Human moDC cultures were activated with LPS as control
(250 ng/ml ultrapure LPS, InvivoGen, 3950 Sorrento Valley Blvd,
San Diego, CA, USA) or with live L. reuteri strains at a non-toxic
ratio of 0.4:1 bacteria:moDCs and were co-cultured for another
24 or 1.5 h.
Flow Cytometry Analysis
Phenotyping of resting and activated moDCs was performed by
flow cytometry using anti-HLA-DR-PE (BD Biosciences), anti-
CD80-FITC, anti-CD83-FITC, anti-CD86-PE (R&D Systems,
Minneapolis, MN, USA) and isotype-matched control antibodies.
To block non-specific antibody binding, heat-inactivated mouse
serum was used. Fluorescence intensities were measured by FACS
Calibur (BD Biosciences). The data were analyzed by the FlowJo
software version 5.7.1 (Tree Star, Ashland, OR, USA).
Measurement of Cytokine
Concentrations
Culture supernatants of moDCs were harvested 24 h after moDC
activation, and the concentration of TNF-α, IL-1β, IL-6, IL-10, IL-
12(p70) and IL-23(p19) cytokines was measured using OptEIA
kits (BD Biosciences, Franklin Lakes, NJ, USA) following the
manufacturer’s instructions.
Measurement of the Polarization of IFNγ
and IL-17-Producing T-Lymphocytes
Activated moDCs were washed and co-cultured with peripheral
blood lymphocytes (PBLs) for 4 days in AIM-V medium
at moDC:T-cell ratios of 1:20. IFNγ and IL-17 secretion
was analyzed using the avidin-horseradish peroxidase based
enzyme-linked ImmunoSpot (ELISPOT) system (NatuTec
GmbH, Herriotstrasse 1, 60528 Frankfurt am Main. Germany).
Lymphocytes activated by phytohaemagglutinin or concanavalin
A were used as positive controls, the co-cultures containing
resting moDCs and T-cells, or T-cells alone served as negative
controls. To detect IL-17 secretion, the plates were coated with
0.5 µg/ml murine anti-human CD3 antibody (BD Biosciences).
The plates were analyzed by using the ImmunoScan plate reader
(Cell Technology Limited, Shaker Heights, OH, USA).
MUB Purification
L. reuteri ATCC 53608 was inoculated from −80◦C glycerol
stocks into the semi-defined substrate medium, LDMII (Kotarski
and Savage, 1979) under anaerobic conditions for 16 h at
37◦C, followed by sub-culture at 0.1% (v/v) for 24 h at 37◦C
to stationary phase. Cells were removed by centrifugation
at 7,500 × g for 15 min at 4◦C. Spent culture medium
was further purified by vacuum-filtration through 0.45 µm
and 0.22 µm filter disks (Merck Millipore, Nottingham, UK),
sequentially, and concentrated by tangential flow filtration using
Vivaflow 200 cassettes (100,000 Da molecular weight cut-off;
Sartorius Stedim, Surrey, UK). The spent culture was further
purified by gel filtration chromatography using a Superose
6 GL 10/300 column (GE Healthcare, Little Chalfont, UK)
with PBS as eluent. To fractionate MUB from co-purifying
glycolipid, CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-
1-propanesulfonate; Sigma Aldrich, Darmstadt, Germany) was
added to 0.5% (w/v) to both the sample and eluent during gel
filtration. The MUB protein (predicted size of 353 kDa) was
eluted in the void volume of the column with and without the
addition of CHAPS and its purity was confirmed by SDS-PAGE.
Before use, MUB was dialyzed extensively against PBS using
Vivaspin 6 spin filters (100 kDa; Sartorius Stedim Ltd, Surrey,
UK) to remove CHAPS.
Endotoxin Removal
The MUB protein solution was further purified according to the
protocol of Zhang et al. (2005). Briefly, Lipid Removal Adsorbent
(2% w/v; Sigma Aldrich, Darmstadt, Germany) was added to the
MUB solution and was incubated under gentle rotation for 2 h at
4◦C. The mixture was then centrifuged at 5,000× g for 10 min at
4◦C and the supernatant collected and stored at 4◦C until use.
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Cell Reporter Assay
BWZ.36 cells expressing murine C-type lectins receptors (CLRs),
mouse Dectin-1 (mDectin-1), and SIGN-R1 were established
as described previously for mouse Dectin-2 (mDectin-2)
(Wittmann et al., 2016). Briefly, the extracellular domain of
mDectin-1 (Ser74 through Leu244) and SIGN-R1 (Ser76 through
Gly324) were cloned separately into the retrovirus vector pMXs-
IRES-EGFP-Ly49A-CD3ζ encoding transmembrane region of
the mouse Ly49A and the cytoplasmic domain of the mouse
CD3ζ (Wittmann et al., 2016). The resulting pMXs vectors
encoding mDectin-1 and SIGN-R1, respectively, were used for
the retrovirus transduction using Plat-E cells (Wittmann et al.,
2016). In order to introduce two amino acid mutations into the
carbohydrate-binding domain of SIGN-R1 (E285Q and D287N),
a DNA fragment encoding the extracellular domain of SIGN-R1
with the two missense mutations was synthesized (Genscript) and
used for cloning as above.
To assess the binding of MUB or lipid component to
CLRs, ligands were adsorbed onto 96-well microplates (Nunc)
overnight at 4◦C. The MUB protein was added at 0.1 mg/ml in
PBS, and the lipid fraction co-purified with the MUB protein
was diluted with PBS at a ratio of 1:1 before adsorption
to the plate. Scleroglucan (1 µg/ml) (ELICITYL), α-mannan
(2 µg/ml) (Sigma–Aldrich), and Hafnia-LPS (1 µg/ml) (a gift
from Dr. Ewa Katzenellenbogen, Ludwik Hirszfeld Institute of
Immunology and Experimental Therapy, Wroclaw, Poland) were
used as specific ligands for mDectin1, mDectin-2 and SIGN-R1,
respectively. Wells were washed twice with PBS, and reporter cells
(1× 106 cells/ml) and were added to each well and incubated for
18 h at 37◦C, 5% CO2. Following incubation, the microwell plates
were centrifuged at 510 × g for 3 min and the supernatant was
discarded. β-galactosidase activity (encoded by the lacZ reporter
gene) was determined by the addition of 200 µL of 150 mM
chlorophenol red-β-D-galactopyrasonide (CPRG; Roche) diluted
in a CPRG assay reaction buffer (PBS supplemented with 0.125%
Triton X-100 and 100 mM 2-mercaptoethanol, Lonza) to each
well. The plate was incubated for 45 min at 37◦C, 5% CO2 prior
to measurement of color development (A570/630 nm) with a
Bio-Rad Benchmark Plus microtiter plate reader.
Adhesion Measurements by Force
Spectroscopy
The interactions between MUB and CRLs were examined
by covalently attaching the MUB molecules to atomic force
microscopy (AFM) tips and DC-SIGN or SIGN-R1 or Dectin-2
to the glass slides to enable binding interactions to be measured
in a specific manner (Hinterdorfer et al., 2002). Silicon nitride
AFM tips (PNP-TR, Nanoworld AG, Neuchâtel, Switzerland) and
freshly cleaned glass slides were functionalized using a four step
procedure (carried out at 21◦C): the first step involved incubation
in a 2% solution of 3-mercaptopropyltrimethoxy silane (MTS,
Sigma–Aldrich, Poole, Dorset, UK) in toluene (dried over a 4Å
molecular sieve) for 2 h, followed by washing with toluene and
then chloroform. In the second step, the silanised tips were
incubated for 1 h in a 1 mg/ml solution of a heterobifunctional
linker: MAL-PEG-SCM, 2 kD (Creative PEGWorks, Chapel
Hill, NC, USA) in chloroform. The silanised glass slides were
incubated in 5 mM N-γ-maleimidobutyryl-oxysuccinimide ester
(GMBS) in ethanol (Thermo Fisher Scientific, Waltham, MA,
USA). The tips and slides were rinsed with chloroform/ethanol,
respectively, and then dried with argon. The third step involved
covalent attachment of the molecules investigated in this study
(i.e., CLRs and MUB) by incubation of the tips/slides in
1 mg/ml solutions of the proteins in PBS at pH 7.4 for
1 h at 21◦C, followed by a PBS washing step. The fourth
step involved incubation of the functionalized cantilevers/slides
in a 10 mg/ml solution of glycine in PBS to ‘amine’-cap
any unreacted succinimide groups, followed by washing in
PBS.
Binding measurements were carried out in PBS using a MFP-
3D BIO AFM (Asylum Research Inc., Santa Barbara, CA, USA).
The experimental data were captured in ‘force-volume’ (FV)
mode at a rate of 2 µm/s in the Z direction and at a scan rate
of 1 Hz and a maximum load force of 300 pN (pixel density
of 32 × 32). The spring constant, k, of the cantilevers was
determined by fitting the thermal noise spectra (Hutter and
Bechhoefer, 1993), yielding typical values in the range 0.03–
0.06 N/m. Adhesion in the force spectra was quantified using
a bespoke Excel macro (Gunning et al., 2008) which fits a
straight line to the baseline of the retract portion of the force-
distance data. In order to explore the specificity of the binding
interactions, the force measurements were repeated after addition
of 0.05 mg/ml anti-Mub antibody (MacKenzie et al., 2010) to the
liquid cell.
In vitro Detection of CLR-Mediated
Inflammatory Responses
To assess the role of CLRs in the induction of moDC-mediated
inflammatory cytokine release, endotoxin-free purified MUB was
coated to sterile high protein-affinity OptEIA ELISA 96-well
plates (BD Biosciences) at 38.5 µg/ml concentration followed
by overnight incubation at 4◦C. After repeated washing steps
with sterile PBS, the cells were co-incubated with moDCs in
the presence or absence of 5 µg/ml anti-Dectin-2 monoclonal
antibody (clone Q7-4B5 InvivoGen) or anti-DC-SIGN (120507
Abcam, Cambridge, UK) antibody for 1 h on ice. After the
washing steps with 5 ml fresh AIM-V medium 2 × 105
moDCs were cultured in microwell plastic plates for 24 h
coated or uncoated with MUB. The concentration of TNF-α
and IL-6 cytokines was measured in the culture supernatants
using OptEIA kits. In another set of experiments, moDCs
were first co-incubated with blocking antibodies specific for
Dectin-2 or DC-SIGN and following a washing step with fresh
AIM-V medium, the cells were co-cultured with L. reuteri
ATCC 53608 or 1063N strains for 1.5 h at 37◦C at a
moDC:bacteria ratio of 1:4. The supernatant was removed by
centrifugation at 1000 rpm for 5 min and the cells washed
repeatedly with 5 ml PBS at 4◦C (five times) followed by
centrifugation at 1000 rpm. Finally, the moDCs were co-cultured
with autologous T-lymphocytes in AIMV medium for 4 days
at a moDC:T-cell ratio of 1:20. The secretion of IFNγ was
analyzed by ELISPOT assay. T-lymphocytes co-cultured with
either resting moDCs, bacteria or culture media served as
negative controls.
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Statistical Analysis
Student’s unpaired two-tailed t-test or ANOVA followed by
Bonferroni’s multiple comparison tests were used as indicated
in the relevant experiments. In case of significantly different
variances (p < 0.05) between the sample sets the Welch’s
correction was applied in the t-test. The results were expressed as
mean + SD. All analyses were performed by using the GraphPad
Prism software, version 6.0. Differences were considered to be
statistically significant at P < 0.05. Significance was indicated as
∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.005; ∗∗∗∗P < 0.0001.
RESULTS
Mucus Adhesins Facilitate the
Phagocytosis of L. reuteri Strains by
moDCs
The L. reuteri strains ATCC PTA 6475 and ATCC 53608 (1063)
express mucus-binding proteins CmbA (Jensen et al., 2014;
Etzold et al., 2014b) and MUB (Etzold et al., 2014a; MacKenzie
et al., 2010), respectively on their cell surface. It is well established
that the phagocytic process of bacteria can modulate the outcome
of immune responses. To assess the impact of mucus adhesins
on the internalization of L. reuteri strains by moDCs, we used
L. reuteri mutant strains, L. reuteri 6475-KO (Jensen et al., 2014;
Etzold et al., 2014b) and 1063N (MacKenzie et al., 2010) deficient
for CmbA and MUB, respectively, in comparison to the wild-type
strains. In these experiments, the moDCs isolated from PBMCs of
healthy blood donors were cultured in serum-free medium in the
presence or absence of ATRA.
When the FITC-labeled strains were incubated with moDCs
at 37◦C for 1.5 h, the L. reuteri 1063N MUB-mutant was
internalized 10-fold less efficiently than its wild-type counterpart
ATCC 53608, and the engulfment of ATCC PTA 6475 was
twofold more efficient than that of the 6475-KO CmbA
mutant strain (Figures 1A,C). Moreover, there were significant
differences (p = 0.0142) between mutant strains with a 10-
fold decreased level of internalized 1063N mutant strain as
compared to the 6475-KO strain. At 4◦C, the phagocytic
process was significantly inhibited but the ratio of adherent
bacteria was higher in the wild-type strains as compared to
the mutants (Figure 1B). The presence of ATRA inhibited the
cell surface expression of CD1a, resulting in CD1a− CD1d+
moDCs (data not shown) but no difference could be detected
in the L. reuteri phagocytic capacity of the cells as compared to
moDCs differentiated in the absence of ATRA. Taken together,
these results demonstrate that the cell-surface expressed mucus
adhesins have the potential to promote the internalization
process by moDCs.
Mucus Adhesins Modulate
moDC-Mediated Immune Responses to
L. reuteri Strains
The moDC activating potential of L. reuteri ATCC PTA 6475
and ATCC 53608, as well as their mutant strains, was further
analyzed by measuring the cell surface expression of CD83,
the co-stimulatory molecules CD80 and CD86, and the major
histocompatibility complex (MHC) class II-protein, HLA-DR,
by flow cytometry. We showed that the cell surface expression
of CD83 was induced by all L. reuteri strains, however, in the
presence of the 1063N mutant, CD83 expression was reduced
significantly, suggesting a potential role of MUB in moDC
activation (Figures 2A,D). Co-culturing moDCs with L. reuteri
strains for 24 h also induced cell surface expression of the co-
stimulatory molecules CD80 and CD86 (Figure 2B) and HLA-
DR (Figure 2C). However, the co-stimulatory potential was
exclusively reduced by 1063N.
The level of moDC-derived pro-inflammatory cytokines
(TNF-α, IL-1β, IL-6) and that of the T-lymphocyte polarizing
cytokines (IL-10, IL-12, IL-23) was monitored upon incubation
with wild-type and mutant L. reuteri strains. L. reuteri ATCC
PTA 6475 induced TNF-α secretion more efficiently than
ATCC 53608. The 6475-KO and 1063N mutants induced lower
levels of TNF-α production than their wild-type counterparts
(Figure 3A). The L. reuteri 1063N mutant was further associated
with lower IL-1β, IL-6 and anti-inflammatory IL-10 production
as compared to the wild-type ATCC 53608 strain (Figure 3B).
Interestingly, both L. reuteri wild-type ATCC PTA 6475 and
mutant 6475-KO induced the secretion of immunoregulatory
IL-10 in moDCs to a similar extent whereas the production of
the inflammatory cytokines (TNF-α, IL-1β, IL-6) was reduced
in presence of 6475-KO. In addition, all L. reuteri strains tested
in these experiments provoked potent IL-12 and IL-23 cytokine
responses as compared to the LPS control (Figure 3C). These
results demonstrated that mucus adhesins expressed by L. reuteri
strains have the potential to enhance pro-inflammatory cytokine
production in moDCs.
Next we addressed the question whether moDC-mediated
T-cell responses targeting L. reuteri mucus adhesin-expressing
strains were able to orchestrate T-lymphocyte polarization. In
this context, moDCs were first exposed to L. reuteri strains or
to LPS used as a control, followed by co-culturing the cells with
autologous T-lymphocytes for 4 days. The secretion of IFNγ and
IL-17 cytokines was monitored at a single cell level by using
the ELISPOT assay with IFNγ or IL-17 specific monoclonal
antibody-coated plates. MoDCs activated by the ATCC PTA
6475 or ATCC 53608 wild-type strains induced IFNγ secretion
by T-lymphocytes (Figure 4A) and resulted in increased IL-17
production (Figure 4B), as compared to the immature moDC:T-
cell co-cultures. In contrast, the L. reuteri 6475-KO and 1063N
mutant strains induced IFNγ producing Th1 cell activation, but
were unable to trigger IL-17 polarized immune responses. Taken
together, these results demonstrate that mucus adhesins are able
to up-regulate immune responses against L. reuteri strains in
moDCs.
Purified Mucus-Binding Protein (MUB)
Triggers CD83 Expression and Provokes
Th1 Polarized Immune Responses in
moDCs
To further characterize the immunomodulatory potential of
L. reuteri strains, native MUB was purified from L. reuteri ATCC
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FIGURE 1 | The phagocytic capacity of moDCs co-cultured with L. reuteri is strain-dependent. Human moDCs were differentiated in the presence of
GM-CSF, IL-4 and with or without 1 nM ATRA for 2 days. On day 2, moDCs were co-cultured with heat-inactivated bacteria at 37◦C (A) or at 4◦C (B) for 1.5 h at a
moDC:bacteria ratio of 1:20. Bacterial uptake was measured by flow cytometry. The number of moDC carrying phagocytosed FITC-labeled bacteria was calculated
from 3 independent experiments + SD. Histogram overlays are shown for one independent experiment (C). Statistical differences were analyzed by ANOVA, with
significance defined as ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001.
53608 spent culture medium, either associated with glycolipids,
or separated from the glycolipid fraction when CHAPS was
employed (Supplementary Figure S1). We investigated the
inflammatory nature of purified, endotoxin-free MUB as
compared to LPS, and also the glycolipid fraction in the
course of the moDC-regulated immune response. Increasing
concentrations of purified MUB induced CD83 expression on the
moDC surface (Figures 5A,C). The cell surface expression of the
CD80 co-stimulatory molecule was also enhanced independent of
MUB concentration, although this effect did not reach statistical
significance (Figures 5B,C). The level of moDC-secreted pro-
inflammatory cytokines, including TNF-α, IL-1β, IL-6, IL-12
and the anti-inflammatory cytokine IL-10 was dependent on
the concentration of MUB, except in the case of IL-6. When
moDCs were cultured in the presence of 0.5 or 1 µg/ml MUB, the
production of IL-10 cytokine, known to have regulatory potential,
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FIGURE 2 | L. reuteri strains modulate the expression of cell surface activation markers in moDC. MoDCs were co-incubated with live L. reuteri strains, or
LPS as a control, for 24 h. The expression of moDC-associated activation marker CD83 (A), co-stimulatory molecules CD80 and CD86 (B) and MHC class
II-protein, HLA-DR (C) was measured by flow cytometry. Mean values were calculated from 5 to 7 independent experiments ± SD. Histogram overlays are shown for
one independent experiment (D). Statistical differences were analyzed by Student’s t-test, with significance defined as ∗P < 0.05, ∗∗p < 0.01, ∗∗∗P < 0.001, and
∗∗∗∗P < 0.0001.
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FIGURE 3 | The secretion of inflammatory and regulatory cytokines is modified in a L. reuteri strain-dependent manner in moDCs. MoDCs were
co-incubated with L. reuteri strains, or with LPS as a control, for 24 h. The concentration of TNFα, IL-1β, IL-6, (A) IL-10 (B), IL-12, IL-23 (C) cytokines was measured
by ELISA in 5 independent experiments. Mean values ± SD are shown. Statistical differences were analyzed by Student’s t-test, with significance defined as
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001.
was found to be in the logarithmic range of 0.01–0.1 ng/ml, while
the concentration of the pro-inflammatory cytokine IL-12 varied
within the 0.1–1 ng/ml range (Figure 5D). Furthermore, moDC
cultures activated with LPS or MUB induced Th1 polarized
immune responses associated with increased IFNγ production
(Figure 5E), in line with the increased concentration of IL-
12. ATRA had no effect on the purified MUB-induced moDC
response (data not shown). The extracted lipid fraction also
induced CD83 and CD86 expression on the moDC cell surface
to a similar extent as induced by the lipid containing MUB
fraction (Supplementary Figure S2A). However, pure MUB
lacking glycolipids was associated with the reduced secretion of
IL-12 and was unable to induce IL-23 production by moDCs
(Supplementary Figure S2B). Furthermore, the lipid fraction was
unable to induce IL-12 or IL-23 production, suggesting that
the immunogenicity of MUB can be enhanced by the lipid
component of this fraction.
The Immunomodulatory Properties of
MUB Are Mediated by DC-SIGN and
Dectin-2 Interactions in moDC
To gain insight into the mechanisms mediating the interaction
of MUB with moDCs, we first tested the binding of MUB to
reporter cells expressing specific CLRs on the cell surface. MUB
significantly bound to murine mDectin-2 and SIGN-R1 (murine
analog of human DC-SIGN) reporter cells in a dose-dependent
manner (Figure 6A). There was no binding to the mock cells
(used as a negative control) and we could not detect any binding
of MUB to mDectin-1 using the same approach. When MUB
was incubated with reporter cells expressing the mDectin-2 QPD
mutant, in which the mannose-binding activity was eliminated
by substituting EPN (glutamic acid-proline-asparagine) sequence
into galactose-type QPD, the binding was reduced, indicating
the specificity of the interaction. Interestingly, the lipid fraction
showed strong interaction with the SIGN-R1 receptor, at a level
similar to that of the positive control, Hafnia alvei LPS, which
has α-linked mannan O-antigen (Wittmann et al., 2016). The
binding of MUB to CLRs was further investigated by atomic force
spectroscopy. In this experiment, MUB was covalently linked to
the functionalized AFM tip, and the CRLs were immobilized onto
the glass slide, taking advantage of specific covalent attachment
chemistry (Bhatia et al., 1989). The modal value of binding
strength (684 pN) revealed a strong interaction between MUB
and DC-SIGN (Figure 6B). The addition of anti-Mub antibody to
the liquid cell significantly inhibited the interaction. The presence
of highly symmetrical negative peaks in both force magnitude
and distance indicates sequential unfolding of Mub multiple
repeats as DC-SIGN and MUB are pulled apart (Carrion-
Vazquez et al., 1999) (Figure 6C). The number of unfolding
events was significantly reduced in the presence of anti-Mub
antibody (Figure 6C). Figures 6D,E show the quantification
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FIGURE 4 | L. reuteri mucus adhesins modulate moDC-mediated
T-lymphocyte polarization. The T-cell activating and polarizing capacity of
moDCs was monitored by activating moDCs with L. reuteri strains or LPS
followed by co-culture with T-cells. T corresponds to T-cells cultured without
dendritic cells as negative control. The mean values of spot numbers were
calculated from five independent experiments + SD. The number of
cytokine-producing T-lymphocytes induced by LPS or moDCs exposed to
L. reuteri strains was measured by ELISPOT assays for IFNγ (A) and IL-17
(B). Statistical differences were analyzed by Student’s t-test, with significance
defined as ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001.
of the binding interactions between MUB and SIGN-R1 or
Dectin-2, respectively.
To gain further insights into the enhanced inflammatory
response induced by bacterial MUB in moDCs, we analyzed
the role of selected CLRs, Dectin-2 and DC-SIGN, upon MUB–
moDC interaction. We found that immobilized MUB activated
the secretion of pro-inflammatory cytokine TNF-α and IL-6
(Figure 7A) and this effect could be prevented in moDCs
efficiently by neutralizing the signal transducer function of
Dectin-2 and DC-SIGN receptors with blocking antibodies
to DC-SIGN or Dectin-2, while IL-1β and IL-12 cytokine
production was not detected (data not shown). Interestingly, we
found that L. reuteri uptake was not eliminated in moDCs in
the presence of anti-DC-SIGN or anti-Dectin-2 antibodies (data
not shown). To confirm the involvement of Dectin-2 and DC-
SIGN in the activation of moDC-mediated T-cell differentiation,
blocking antibodies targeting these cell surface CLRs were used
in the presence of L. reuteri ATCC 53608 and 1063N (Figure 7B).
The Th1 polarizing capacity of moDCs induced by the wild-
type strain was reduced in presence of anti-Dectin-2 or anti-
DC-SIGN antibodies as compared to CLR-unblocked moDCs.
As expected, the Th1 polarizing capacity of the mutant strain
1063N was not affected by blocking DC-SIGN and Dectin-2 on
moDCs. These results clearly demonstrate that the interaction of
Dectin-2 and DC-SIGN with MUB presented by L. reuteri ATCC
53608 is crucial to acquire Th1-cell differentiation upon bacterial
stimulation of moDCs.
DISCUSSION
Probiotic lactobacilli, as part of the healthy microbiota, have
been reported to regulate mammalian cytokine production and
intestinal inflammation in various experimental model systems
(van Baarlen et al., 2013). However, it is also clear that the
immunomodulatory effects of probiotic strains such as L. reuteri
are strain-dependent, exerting different DC activation patterns
in vitro. For example, L. reuteri strains ATCC PTA 6475 and
ATCC PTA 5289 were reported to suppress the production
of TNF-α by LPS-activated monocytic cells (Lin et al., 2008;
Jones and Versalovic, 2009), whereas the L. reuteri strains ATCC
55730 and CF48–3A were shown to have an immuno-stimulatory
effect (Lin et al., 2008; Jones and Versalovic, 2009). A similar
down-regulation of pro-inflammatory cytokines (e.g., TNF-α)
by L. reuteri ATCC PTA 6475 was also observed with primary
monocyte-derived macrophages from children with Crohn’s
disease (Peña et al., 2005). Christensen et al. (2002) showed that
the L. reuteri DSM 12246 strain was a poor inducer of IL-12, TNF-
α, and IL-6 in bone marrow-derived murine DCs. Moreover, a
more recent study showed that L. reuteri strains from human-
associated clades differed in respect to their ability to modulate
human cytokine production (TNF-α, monocyte chemoattractant
protein-1 (MCP-1), IL-1β, IL-5, IL-7, IL-12, and IL-13) by
stimulated myeloid cells (Spinler et al., 2014). Although not well
understood, it is likely that the sum of bacterial cell surface-
derived and soluble factors and/or exopolysaccharides (EPS)
contribute to the development of different immune responses
induced by L. reuteri strains. For example, soluble factors of
L. reuteri CRL1098 were able to reduce TNF-α production by
human PBMCs (Mechoud et al., 2012) and in mouse models
(Griet et al., 2014). Furthermore, human moDCs generated in the
presence of the soluble factors of L. reuteri DSM 17938 down-
modulated LPS-induced IL-6, IL-10, and IL-23 secretion while
the secretion of regulatory cytokine TGF-β remained unaffected
(Haileselassie et al., 2016). EPS isolated from L. reuteri strain
DSM 17938 and L26 BiocenolTM was recently shown to exert
up-regulation of the mRNA level of IL-1β, NF-κB, TNF-α, and
IL-6 (Kšonžeková et al., 2016). One of the putative L. reuteri
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FIGURE 5 | Purified MUB protein triggers CD83 expression and induces Th1 polarized immune responses. Increasing concentrations of purified MUB was
used to activate 2-day moDC cultures. LPS was used as a positive control. Cells were activated for 24 h and the cell surface expression of CD83 (A) and the
co-stimulatory molecule CD80 (B) was measured by flow cytometry. Mean fluorescence intensity (MFI) and the ratio of CD83 positive cells were calculated from
three independent experiments + SD. Histogram overlays are shown for one independent experiment (C). Production of inflammatory cytokines TNFα, IL-1β, IL-6,
IL-12 and the regulatory cytokine IL-10 in the supernatants of moDCs was detected after 24 h by ELISA. Mean values of cytokine concentrations were calculated
from 3 independent experiments + SD (D). Freshly isolated PBLs were co-cultured with autologous moDCs for 4 days. The number of cytokine-producing PBLs in
response to LPS as control or MUB-exposed human moDCs was measured by IFNγ ELISPOT assay. Mean values of spot numbers were calculated from 3
independent experiments ± SD (E). Statistical differences were analyzed by Student’s t-test, with significance defined as ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and
∗∗∗∗P < 0.0001.
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FIGURE 6 | Interaction of MUB with C-type lectin receptors. (A) Cell reporter assays were carried out to screen the interaction of MUB and MUB-derived lipid
with CLRs (a), mDectin-2 and QPD-mutant reporter cells (b), SIGN-R1 and QPD-mutant reporter cells (c). Scleroglucan, α-mannan, and Hafnia alvei LPS were used
as a positive control for mDectin-1, mDectin-2, and SIGN-R1, respectively. Statistical differences were determined by ANOVA, with significance defined as ∗P < 0.05,
∗∗P < 0.01, and ∗∗∗P < 0.001. Force spectroscopy was used to measure the direct interaction between MUB functionalized AFM tip and CLRs. (B) Adhesion
histograms between MUB and DC-SIGN. (C) Example of interaction force spectroscopy curves (Red – approach, Blue – retract) (a) MUB tip against DC-SIGN in
PBS (b) MUB tip against DC-SIGN in presence of anti-Mub antibody. (D) Adhesion histogram of MUB and SIGNR1. (E) Adhesion histogram of MUB and Dectin-2.
surface proteins appeared to be important for the stimulation
of THP-1 cells and the activation of NF-κB in U937-3xkB-
LUC cells by L. reuteri strains (Jensen et al., 2015). However,
the specific mechanisms by which bacterial molecules could
modulate cytokine expression in antigen-presenting cells remains
to be identified.
Here we showed that host strain-specific adhesins contribute
to the immunomodulatory effect of L. reuteri ATCC PTA
6475 and ATCC 53608 mediating (i) increased adherence and
phagocytosis of L. reuteri strains by moDCs, (ii) enhanced
CD83 expression, (iii) induced secretion of pro-inflammatory
cytokines (TNF-α, IL-1β, IL-6) and that of the T-lymphocyte
polarizing cytokines IL-12 and IL-23, and (iv) Th1 and Th17-
polarized immune responses characterized by IFNγ and IL-
17 production, respectively. Both wild-type ATCC PTA 6475
and ATCC 53608 showed higher internalization by moDCs
and increased expression of moDC activation markers as
compared to the mucus adhesin mutant strains. However,
strain-specific differences were observed in terms of cytokine
production; TNF-α was induced preferentially in moDCs
activated by the CmbA-expressing strain ATCC PTA 6475,
while the MUB-expressing ATCC 53608 strain induced IL-
1β and IL-6 secretion. It is worth noting that L. reuteri
ATCC PTA 6475 is generally considered as anti-inflammatory
due to its reported ability to inhibit or down-regulate pro-
inflammatory cytokines such as TNF-α, MCP-1, IL-1β, and
IL-12 in stimulated myeloid cells (Lin et al., 2008), consistent
with the known ability of L. reuteri strain ATCC PTA 6475
to suppress intestinal inflammation induced by LPS (Liu et al.,
2010). Here we showed that, in absence of stimulatory signals
mediated by LPS-induced PRRs, the immunogenicity of L. reuteri
strains was increased by mucus-binding adhesins, and that the
mutant strains showed a more tolerogenic immune response
represented by decreased Th1 and Th17 immune responses, an
effect which involves the CLR-induced signaling pathways in
moDCs.
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FIGURE 7 | The molecular background of bacterial MUB adhesin – moDC interaction causing inflammation and T-lymphocyte polarization. (A) MUB
immobilized on a microtiter plate was incubated with 2-day moDC cultures treated with anti-Dectin-2 or anti-DC-SIGN antibodies. Unlabeled (ctrl) moDCs incubated
on MUB-coated and uncoated wells served as negative and positive controls, respectively. The production of pro-inflammatory TNF-α and IL-6 cytokines was
measured by ELISA after 24 h. Mean value of cytokine concentrations was calculated from 5 independent experiments + SD. (B) MoDCs treated with anti-Dectin-2
or anti-DC-SIGN antibodies were co-cultured with live L. reuteri ATCC 53608 and 1063N strains for 1.5 h at 37◦C, respectively. Freshly isolated PBLs were
co-cultured with autologous moDCs for 4 days. The number of cytokine-producing T-cells was measured by IFNγ ELISPOT assay. Mean values of spot numbers
were calculated from 5 independent experiments + SD. T corresponds to T-cells cultured without dendritic cells as negative control. Statistical differences were
analyzed by Student’s t-test, with significance defined as ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001.
C-type lectin receptors represent one subset of PRRs expressed
by a broad spectrum of cells (Meyer-Wentrup et al., 2005)
and recognize a diverse range of endogenous and exogenous
ligands including fungi, bacteria, parasites, and danger-associated
molecular patterns driving both innate and adaptive immunity
(Gijzen et al., 2006; Sukhithasri et al., 2013). The mechanism
by which MUB exerts immunomodulatory effects was further
investigated using a cell reporter assay specific for different
CLRs showing that purified MUB from L. reuteri ATCC
53608 was recognized by mDectin-2 and SIGN-R1 but not by
mDectin-1. Dectin-1 is the major receptor on macrophages
for β-1,3-glucan, a polymer of glucose present in the fungal
cell wall (Herre et al., 2004) whereas Dectin-2, expressed by
macrophages and various DC subsets recognizes high-mannose
ligands found in diverse microbes, including Candida albicans
(Zhu et al., 2013), Malassezia furfur (Ishikawa et al., 2013), and
Schistosoma mansoni (Ritter et al., 2010). DC-SIGN (or CD209)
is expressed in sub-epithelial DC subsets including CD1c+
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and inflammatory DCs, both having the potential to modulate
PRR-mediated signaling pathways (Soilleux, 2003; Geijtenbeek
and Gringhuis, 2009). SIGN-R1, or CD209b, is one of the
eight mouse homologs of human DC-SIGN (Park et al., 2001;
Kang et al., 2003; Powlesland et al., 2006). These CLRs bind
a broad variety of pathogenic microbial organisms and their
polysaccharides (Geijtenbeek and Gringhuis, 2016) such as HIV
virus (Geijtenbeek et al., 2000), mycobacteria (Geijtenbeek et al.,
2003), C. albicans (Cambi et al., 2003; te Riet et al., 2015),
Streptococcus pneumoniae (Kang et al., 2004) or Helicobacter
pylori (Bergman et al., 2004) and serve as a target of penetration
and infection in the host’s cell while the specific immune response
is prevented (van Kooyk et al., 2003). The direct interaction of
MUB with DC-SIGN, SIGN-R1 and Dectin-2 was confirmed
by atomic force spectroscopy. We clearly demonstrated that
purified MUB, either in solution or immobilized, induced the
secretion of inflammatory cytokines in moDCs. Furthermore,
secretion of TNF-α and IL-6, but not IL-1β or IL-12, was reduced
by the neutralization of the Dectin-2 and DC-SIGN-mediated
inflammatory signaling pathways. These results suggest that the
enhanced level of inflammatory Th1 and Th17 immune responses
provoked by wild-type L. reuteri ATCC 53608 is dependent on the
intimate interaction between MUB and the surface C-type lectin
receptors of moDCs. Surprisingly, the uptake of L. reuteri ATCC
53608 was not affected in moDCs upon the selective blocking of
DC-SIGN or Dectin-2. On the other hand, DC-SIGN and Dectin-
2 receptors played a crucial role in moDC-mediated Th1 type
immune responses against L. reuteri ATCC 53608.
DC-SIGN present on immature DCs appears to be a
general receptor for microbes leading to downstream T cell
activation (Gijzen et al., 2007). DC-SIGN signaling stimulates
tolerance responses in DCs, which is an important component
in maintenance of homeostasis (Geijtenbeek and Gringhuis,
2009; Rabinovich, 2010; Wells, 2011) and can be elicited by
specific lactobacilli (Penders et al., 2010) including strains
of L. rhamnosus (Konieczna et al., 2015), L. acidophilus
(Martínez et al., 2012), L. reuteri and L. casei (Smits et al.,
2005). Interestingly, Lactobacillus cell surface proteins, such
as L. rhamnosus proteinaceous pili (Tytgat et al., 2016) and
L. acidophilus S-layer proteins (Konstantinov et al., 2008;
Martínez et al., 2012; Prado Acosta et al., 2016) have recently
been implicated in the interaction of Lactobacillus spp. with
DC-SIGN. L. rhamnosus GG pili bind to mucus (Kankainen
et al., 2009) and interact with macrophages (Vargas García et al.,
2015). Recently, purified SpaCBA pili of L. rhamnosus GG were
shown to directly interact with DC-SIGN in a carbohydrate-
dependent manner and induce IL-6, IL-10, IL-12p40, and IL-
12p35 expression in DCs (Tytgat et al., 2016). The induction of
these cytokines was partially dependent on DC-SIGN (Tytgat
et al., 2016), in agreement with the reported impact of pili
on TLR-2 signaling (Douillard et al., 2013; von Ossowski
et al., 2013), which might be modulated by DC-SIGN, and the
ability of L. rhamnosus GG wild-type and mutant strains to
modulate several pro- and anti-inflammatory cytokines (Lebeer
et al., 2012; von Ossowski et al., 2013; Vargas García et al.,
2015). Our results indicated that TNF-α and IL-6 secretion
but no other inflammatory cytokines and chemokines was
dependent on both Dectin-2 and DC-SIGN upon interaction
with MUB, which suggest that other PRRs are also involved
in this process. As far as we know, Dectin-2 has not been
implicated in Lactobacillus immunomodulation (van Baarlen
et al., 2013). Previous studies on fungal pathogens showed that
the activation of Dectin-2 but not Dectin-1, led to the secretion
of IL-23 and IL-1β, supporting the polarization of Th17 cells
(Gringhuis et al., 2011; Loures et al., 2015). Here, L. reuteri
1063N mutant was less effective at inducing IL-1β secretion
but no difference could be detected between the IL-23 secretion
levels induced by the wild-type and the mutant L. reuteri strains.
However, the prevention of molecular interaction between
Dectin-2 and immobilized MUB reduced the production of IL-
6, but not IL-1β, in moDCs indicating that IL-6 may serve
as a pivotal factor in L. reuteri ATCC 53608-induced Th17
polarization.
Taken together, these data provide novel insights into the
mechanisms by which L. reuteri strains exert immunomodulatory
properties via the direct interaction of L. reuteri host-specific
adhesins with C-type lectins on DCs. The mucus-binding
adhesins expressed on the surface of L. reuteri bacteria may
contribute to the maintenance of the symbiotic relationship
with the host by acting as a natural adjuvant, thus provoking
antigen-specific adaptive immune responses by moDCs through
the development of effector and memory T-lymphocytes with
sufficient stimulatory potential. Further research is warranted
to assess the pivotal role of protein–glycan interactions in the
immunomodulatory capacities of probiotic strains.
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